NEWS & INSIGHTS
Drug pricing and impact investing
Background President Biden’s Build Back Better agenda has reignited the debate about drug pricing. Arguments generally fall into two camps....
How a 32-year long investment strategy sustains profitable growth into an uncertain future
Investors are keenly focused on how policymakers will react to current levels of inflation. Will it subside without robust intervention...
Pengana Capital chief executive Russel Pillemer wants the numbers to do the talking
By David Ross Journalist - The Australian, January 2022 For years, they were the geniuses of stockpicking – but 2021...
PIA – upcoming fully franked quarterly dividend
Announcing a 1.35 cents per share fully franked quarterly dividend It is our pleasure to advise that the Board of...
WHEB’s approach to biodiversity
Climate change has become such an all-encompassing threat, that most other environmental concerns have been left in its shadow. The...
A stellar year for REITs – will this continue into 2022?
With the clock ticking over to 2022, the world will have endured two years of COVID-19. Despite the well-documented challenges,...
WHEB wins “European ESG Manager of the Year” in the Funds Europe Awards 2021
WHEB Asset Management wins “European ESG Manager of the Year” in the Funds Europe Awards 2021. Now in their 17th...
A Frontline View on Inflation and Its Persistence
Anecdotal reports from the companies we follow indicate differing impacts from rising prices—and offer a few clues to where inflation...
How a simple investment process led to Facebook, Moderna
Original article Axiom Investors’ Bradley Amoils is looking for only one kind of stock: a company changing dynamically, with sustainable...